Get the Stockscreener App
25.34
0.24%
-0.06
Roundhill Glp 1 Weight Loss Etf stock is traded at $25.34, with a volume of 7,075.
It is down -0.24% in the last 24 hours and up +4.54% over the past month.
See More
Previous Close:
$25.40
Open:
$25.56
24h Volume:
7,075
Relative Volume:
0.28
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+3.39%
1M Performance:
+4.54%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$25.30
$25.60
1-Week Range:
$24.02
$25.60
52-Week Range:
$23.21
$29.21
Roundhill Glp 1 Weight Loss Etf Stock (OZEM) Company Profile
Name
Roundhill Glp 1 Weight Loss Etf
Sector
Industry
Phone
-
Address
-
Compare OZEM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OZEM
Roundhill Glp 1 Weight Loss Etf
|
25.34 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
298.00 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
600.77 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
603.80 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
247.71 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
522.92 | 124.43B | 0 | 0 | 0 | 0.00 |
Roundhill Glp 1 Weight Loss Etf Stock (OZEM) Latest News
Slower flows, small-cap woes, SEC nos! What to expect from ETFs in 2025 - Citywire Professional Buyer
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip - MSN
New Year's Resolutions: Lose Weight & Allocate to GLP-1 ETFs - ETF Trends
Roundhill Investments Surpasses $4 Billion AUM Milestone – Company Announcement - Financial Times
Eli Lilly Cuts Q4 Sales Forecast: ETFs To Buy On The Dip - Barchart
Eli Lilly Lowers Q4 Sales Outlook: Best ETFs to Consider Now - espeaks.co.uk
ROUNDHILL -- A "Roundhill Roundup" -- all Roundhill Investments products since inception - substack.com
Jane Street Group LLC Has $1.16 Million Stock Position in Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) - Defense World
Disruptive Theme of the Week: 2024's Top Investment Themes & Trends - ETF Trends
Eli Lilly Stock Soars 34.42% YTD: A $1000 Investment Outpaces Returns From These ETFs Holding Mounjaro-Maker Shares - Benzinga
Disruptive Theme of the Week: Breakthroughs in Medicine - ETF Trends
Tap the Weight-Loss Drug Market With These ETFs - Yahoo Finance
Roundhill Investments Surpasses $2 Billion AUM Milestone – Company Announcement - Financial Times
Mag7, AI and GLP-1: Roundhill CEO on the hottest ETFs to watch - CNBC
Disruptive Theme of the Week: Playing Defense - ETFdb.com
Ozempic and Weight Loss Drug ETFs Back in Spotlight After Key Earnings Results - Trackinsight
5 ETFs to Make the Most of Eli Lilly's Strength - Yahoo Finance
Dr. Sanjay Gupta On Call: What are your questions about weight loss drugs? - Yahoo Lifestyle UK
Weight loss drug may cut heart failure risk, company says - Yahoo News Australia
ETFs in Focus as Competition Heats Up in Weight Loss Drug Segment - Yahoo Finance
A weight loss miracle! New shot does better than Ozempic and Wegovy during trials - Yahoo Singapore News
Why Investors Haven't Feasted on Two New Weight-Loss ETFs - Investopedia
Obesity drug used in Mounjaro and Zepbound may help treat dangerous sleep apnea - Yahoo Canada Shine On
Weight-loss ETFs demand some heavy thinking - Financial Times
Diabetes drug recommended to treat obesity on the NHS - Yahoo News UK
ETFs to Profit from the Weight Loss Drug Boom - Yahoo Finance
New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk - Markets Insider
OZEM, Weight Loss Drug ETFs: Should You Invest? - etf.com
Did South Park mark the top for weight-loss stocks? - Sherwood News
OZEM ETF: 7 Things to Know About the New Roundhill GLP-1 & Weight Loss ETF - InvestorPlace
This new weight loss drug ETF bets big on two of the industry's leading players - CNBC
This Week in ETFs: Roster of 17 New ETFs Includes 6 Buffer Funds - ETF Trends
South Park Took On Crypto, AI Previously: Animated Comedy Targets Weight-Loss Drug Ozempic Next - Benzinga
Play These New ETFs to Tap Lucrative Weight Loss Drug Market - Yahoo Finance
ETFs Targeting Weight-Loss Market Gain Traction - Finimize
Roundhill Investment launches GLP-1 & Weight Loss ETF (NASDAQ:OZEM) - Seeking Alpha
Fund Files: Eaton Vance, Voya PMs to depart; Roundhill launches active weight loss ETF - Citywire Professional Buyer
EXCLUSIVE: GameStop, AMC Buzz 'May Prove To Be Short-Lived,' CEO Of Company Behind MEME ETF Tells Benzinga - Markets Insider
Thematic ETF Winners of the Q1 2024 Earnings Season - ETF Trends
Tori Spelling reveals she tried Ozempic, Mounjaro after birth of fifth child - Yahoo Lifestyle Australia
Roundhill names new CEO - Citywire Professional Buyer
Weight Loss Drugs Zepbound and Mounjaro Are in Shortage Due to 'Demand Increase,' FDA Says - Yahoo News Canada
Two fresh ways to play the weight loss and megacap tech hype - CNBC
Experts hesitate on weight loss ETFs amid the obesity drug boom - CNBC
Roundhill Investments - etf.com
Roundhill Glp 1 Weight Loss Etf Stock (OZEM) Financials Data
There is no financial data for Roundhill Glp 1 Weight Loss Etf (OZEM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.64%
Cap:
|
Volume (24h):